Astarta (AST) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
2025 was a challenging year with consolidated revenues falling 23% year-over-year to EUR472m, mainly due to lower harvests, reduced crop and sugar sales volumes, and lower prices; export sales comprised 62% of total revenue.
Soybean processing and cattle farming segments showed revenue growth and operational resilience, though EBITDA in these segments declined sharply.
EBITDA margin contracted from 26% to 21%, with EBITDA down 37% to EUR100m; net profit was EUR20m, a 76% decline year-over-year.
Financial highlights
Revenues declined in agriculture and sugar due to lower volumes and prices, while soybean processing and cattle farming remained robust in revenue but saw EBITDA declines.
Operating cash flow declined 78% year-over-year to EUR36m, mainly due to a 16% increase in inventories.
Investing cash flows doubled, driven by ongoing investments in the SPC facility, machinery renewal, and maintenance CapEx.
Net debt to EBITDA increased to 2.3x by year-end, with total net debt doubling to EUR226m.
Outlook and guidance
Crop rotation mix for the current year is stable, with a slight decrease in sugar beet acreage and a slight increase in corn at the expense of wheat.
Sugar beet acreage expected to decrease by at least 20% in 2026, potentially relieving domestic oversupply.
SPC facility launch planned for the second half of 2025/2026, with margin uplift expected from 2026; multi-seed crusher project timeline extended beyond 2026.
CapEx in 2026 projected to be less than half of 2025 levels due to market downturns.
Latest events from Astarta
- Net profit and margins rose on stable revenue, with CapEx focused on protein and oilseed projects.AST
Q4 20249 Jul 2026 - Revenue up 5% year-over-year, but net loss of EUR12.3m due to margin and price pressures.AST
Q1 202622 May 2026 - Revenue up 12% y-o-y to EUR321m, but profit and margins fell amid market and regulatory risks.AST
Q2 202422 Jan 2026 - Revenue up 13%, net profit up 35%, and export share at 64% amid strong cash flow.AST
Q3 202412 Jan 2026 - Revenue fell 29% year-over-year, but EBITDA margin rose to 36% amid major investments and market risks.AST
Q2 202523 Nov 2025 - Revenue and profit fell sharply, margins compressed, and net debt surged amid war and weak crops.AST
Q3 202521 Nov 2025 - Revenue down 25% year-over-year, EBITDA margin up to 21%, Ukraine conflict a key risk.AST
Q1 202520 Nov 2025